CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 59 filers reported holding CRINETICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,193,340 | +65.0% | 141,000 | 0.0% | 5.38% | +146.8% |
| Q2 2023 | $2,540,820 | +12.2% | 141,000 | 0.0% | 2.18% | +16.6% |
| Q1 2023 | $2,264,460 | -12.2% | 141,000 | 0.0% | 1.87% | +0.2% |
| Q4 2022 | $2,580,300 | -6.8% | 141,000 | 0.0% | 1.87% | +13.7% |
| Q3 2022 | $2,769,000 | +5.3% | 141,000 | 0.0% | 1.64% | -3.6% |
| Q2 2022 | $2,630,000 | -15.0% | 141,000 | 0.0% | 1.70% | +11.7% |
| Q1 2022 | $3,095,000 | -22.7% | 141,000 | 0.0% | 1.52% | +5.1% |
| Q4 2021 | $4,006,000 | +35.0% | 141,000 | 0.0% | 1.45% | +69.5% |
| Q3 2021 | $2,968,000 | -93.3% | 141,000 | 0.0% | 0.86% | -92.5% |
| Q2 2021 | $44,282,000 | +1955.8% | 141,000 | 0.0% | 11.37% | +2168.7% |
| Q1 2021 | $2,154,000 | +8.2% | 141,000 | 0.0% | 0.50% | +8.9% |
| Q4 2020 | $1,990,000 | -9.9% | 141,000 | 0.0% | 0.46% | -48.3% |
| Q3 2020 | $2,209,000 | -10.6% | 141,000 | 0.0% | 0.89% | +25.5% |
| Q2 2020 | $2,470,000 | +19.2% | 141,000 | 0.0% | 0.71% | +14.4% |
| Q1 2020 | $2,073,000 | -41.4% | 141,000 | 0.0% | 0.62% | -19.4% |
| Q4 2019 | $3,538,000 | +66.8% | 141,000 | 0.0% | 0.77% | +19.8% |
| Q3 2019 | $2,121,000 | -49.4% | 141,000 | -15.9% | 0.64% | -42.9% |
| Q2 2019 | $4,193,000 | +9.9% | 167,700 | 0.0% | 1.12% | +7.5% |
| Q1 2019 | $3,817,000 | -24.1% | 167,700 | 0.0% | 1.05% | -24.2% |
| Q4 2018 | $5,029,000 | +4.7% | 167,700 | 0.0% | 1.38% | +57.9% |
| Q3 2018 | $4,805,000 | – | 167,700 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |